Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.91% | 408.98% | 125.99% | 8.94% | 13.65% |
| Total Depreciation and Amortization | -2.52% | 19.12% | -12.34% | -8.77% | -13.49% |
| Total Amortization of Deferred Charges | -- | -14.09% | -- | -- | -- |
| Total Other Non-Cash Items | 79.45% | -80.89% | 351.19% | 75.30% | -33.48% |
| Change in Net Operating Assets | 116.11% | -82.32% | 67.00% | -84.81% | -340.06% |
| Cash from Operations | 165.05% | -2.84% | 110.75% | -2.29% | -56.82% |
| Capital Expenditure | -10.33% | -73.42% | 10.24% | 13.19% | 41.53% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.30% | -69.32% | 161.52% | -- | 110.80% |
| Cash from Investing | -749.09% | -1,838.18% | 34.44% | -17.67% | 102.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -650.00% | -- | -142.11% |
| Issuance of Common Stock | 53.99% | 260.18% | 101.45% | -14.46% | -6.40% |
| Repurchase of Common Stock | 21.82% | 56.98% | 99.84% | 98.36% | -85.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.92% | -0.78% | 0.49% | 2.09% | 1.92% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 137.07% | 63.29% | 37.22% | 41.57% | -282.02% |
| Foreign Exchange rate Adjustments | 79.59% | -101.93% | -9.90% | 107.55% | -123.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 595.38% | 155.13% | 200.17% | 379.42% | -148.18% |